Building viruses that kill cancer cells: BeneVir gets $2M, waiting on $10M more
Immunotherapy is at the forefront of cancer care; however, most cancers evolve the ability to dodge the body’s defenses. Maryland startup BeneVir is developing immunotherapy viruses that rid the body of two types of tumor cells – those that cause cancer and the ones that make it recurrent. The three-year-old company just closed the first […]